Skip to main content
. 2020 Oct 12;9(10):3264. doi: 10.3390/jcm9103264

Figure 3.

Figure 3

Tumour-bearing survival after recurrence in 13 recurred cases. Early initiation of sirolimus (SRL) at 1 month after living-donor liver transplantation significantly prolonged survival after recurrence compared with tacrolimus (TAC) (p = 0.01).